Spirig Pharma Ltd.: Clinical Trials

1 trial sponsored by Spirig Pharma Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Spirig Pharma Ltd.: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients
MD-3511356, Standard Sun Protection Measures - Actinic Keratoses, Squamous Cell Carcinomas
Phase 3TerminatedSpirig Pharma Ltd.2442010-11-012016-01-08

Conditions studied

Carcinoma, Squamous Cell (1)  ·  Keratosis, Actinic (1)

Countries

Austria (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Claas Ulrich, MD (1)